Nuvation Engineering

Nuvation Engineering company information, Employees & Contact Information

Founded in 1997, Nuvation Engineering is an electronic design company that provides hardware design, software development, and FPGA design services for electronic product development. We are headquartered in Silicon Valley, California, with a Design Center in Waterloo, Ontario, Canada. With over 25+ years of providing engineering services, we have developed our own project management and engineering methodologies, using them with 300+ customers over 1000+ projects.

Company Details

Employees
39
Founded
-
Address
1260 Birchwood Drive, Sunnyvale,ca 94089,united States
Phone
408-228-5580
Email
in****@****ion.com
Industry
Engineering Services
NAICS
Engineering Services
HQ
Sunnyvale, CA
Looking for a particular Nuvation Engineering employee's phone or email?

Nuvation Engineering Questions

News

Nuvation goes early with Ibtrozi | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Nuvation goes early with Ibtrozi | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Why Nuvation Bio Stock Is Skyrocketing Today - The Motley Fool

Why Nuvation Bio Stock Is Skyrocketing Today The Motley Fool

Nuvation Bio stock climbs 16.67% on FDA approval of lung cancer drug - Mugglehead Magazine

Nuvation Bio stock climbs 16.67% on FDA approval of lung cancer drug Mugglehead Magazine

All You Need to Know About Nuvation Bio (NUVB) Rating Upgrade to Buy - Yahoo Finance

All You Need to Know About Nuvation Bio (NUVB) Rating Upgrade to Buy Yahoo Finance

Nuvation Bio to Report Second Quarter 2025 Financial Results and Provide Business Update on August 7, 2025 - Business Wire

Nuvation Bio to Report Second Quarter 2025 Financial Results and Provide Business Update on August 7, 2025 Business Wire

Why I'm Avoiding Nuvation Bio Despite Its Recent FDA Approval (NYSE:NUVB) - Seeking Alpha

Why I'm Avoiding Nuvation Bio Despite Its Recent FDA Approval (NYSE:NUVB) Seeking Alpha

US FDA approves Nuvation Bio's rare lung cancer drug - Reuters

US FDA approves Nuvation Bio's rare lung cancer drug Reuters

David Hung's Nuvation Bio wins FDA approval for Ibtrozi to challenge Pfizer, BMS and Roche in lung cancer field - Fierce Pharma

David Hung's Nuvation Bio wins FDA approval for Ibtrozi to challenge Pfizer, BMS and Roche in lung cancer field Fierce Pharma

Nuvation Scores First FDA Nod With Oral Lung Cancer Drug - BioSpace

Nuvation Scores First FDA Nod With Oral Lung Cancer Drug BioSpace

Nuvation Energy’s battery management solution, powered by ADI - Enlit World

Nuvation Energy’s battery management solution, powered by ADI Enlit World

Nuvation Bio: Up To $250 Million In Non-Dilutive Financings Secured - Pulse 2.0

Nuvation Bio: Up To $250 Million In Non-Dilutive Financings Secured Pulse 2.0

Nuvation gets in before Nuvalent | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Nuvation gets in before Nuvalent | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Nuvation Bio Reports Second Quarter 2025 Financial Results and Provides Business Update - Business Wire

Nuvation Bio Reports Second Quarter 2025 Financial Results and Provides Business Update Business Wire

Nuvation Bio: A Rare Gem In The Risky Biotech Space (NYSE:NUVB) - Seeking Alpha

Nuvation Bio: A Rare Gem In The Risky Biotech Space (NYSE:NUVB) Seeking Alpha

Nuvation Bio: What To Expect From IBTROZI Launch? (NYSE:NUVB) - Seeking Alpha

Nuvation Bio: What To Expect From IBTROZI Launch? (NYSE:NUVB) Seeking Alpha

Jefferies 2024 – Nuvation lays out its US taletrectinib strategy | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Jefferies 2024 – Nuvation lays out its US taletrectinib strategy | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Nuvation Bio: A Justified Fall Based On Post-Marketing Requirements (NYSE:NUVB) - Seeking Alpha

Nuvation Bio: A Justified Fall Based On Post-Marketing Requirements (NYSE:NUVB) Seeking Alpha

Nuvation Bio Secures Up to $250 Million in Non-Dilutive Financings from Sagard Healthcare Partners - Business Wire

Nuvation Bio Secures Up to $250 Million in Non-Dilutive Financings from Sagard Healthcare Partners Business Wire

Nuvation Bio: Judgement Day Grows Closer (NYSE:NUVB) - Seeking Alpha

Nuvation Bio: Judgement Day Grows Closer (NYSE:NUVB) Seeking Alpha

Nuvation Bio Inc. (NUVB) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance

Nuvation Bio Inc. (NUVB) Reports Q2 Loss, Beats Revenue Estimates Yahoo Finance

Confirming Nuvation’s AnHeart takeover | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Confirming Nuvation’s AnHeart takeover | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

JMP Maintains “Market Outperform” on Nuvation (NUVB) for IBTROZI Launch Plans - Yahoo Finance

JMP Maintains “Market Outperform” on Nuvation (NUVB) for IBTROZI Launch Plans Yahoo Finance

Nuvation takes the battle to Nuvalent | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Nuvation takes the battle to Nuvalent | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

FDA priority review for Nuvation Bio's taletrectinib - The Pharma Letter

FDA priority review for Nuvation Bio's taletrectinib The Pharma Letter

Nuvation Bio Receives Approval from Japan’s Ministry of Health, Labour and Welfare for IBTROZI - Business Wire

Nuvation Bio Receives Approval from Japan’s Ministry of Health, Labour and Welfare for IBTROZI Business Wire

Nuvation Bio Stock Gains Momentum Amid Analyst Upgrades and Strategic Engagement - StocksToTrade

Nuvation Bio Stock Gains Momentum Amid Analyst Upgrades and Strategic Engagement StocksToTrade

Nuvation Bio Inc. (NUVB): Among the Best NYSE Penny Stocks to Buy According to Analysts - Yahoo Finance

Nuvation Bio Inc. (NUVB): Among the Best NYSE Penny Stocks to Buy According to Analysts Yahoo Finance

Nuvation Bio Enrolls First Patient in TRUST-IV Phase 3 Study of IBTROZI™ (taletrectinib) for the Adjuvant Treatment of ROS1-Positive Early-Stage Non-Small Cell Lung Cancer - Business Wire

Nuvation Bio Enrolls First Patient in TRUST-IV Phase 3 Study of IBTROZI™ (taletrectinib) for the Adjuvant Treatment of ROS1-Positive Early-Stage Non-Small Cell Lung Cancer Business Wire

Nuvation issues trial update as Jefferies says buy (NUVB) - Seeking Alpha

Nuvation issues trial update as Jefferies says buy (NUVB) Seeking Alpha

Nuvation Bio nabs $250 million to launch cancer drug - The Pharma Letter

Nuvation Bio nabs $250 million to launch cancer drug The Pharma Letter

Is Nuvation Bio (NYSE:NUVB) Using Debt In A Risky Way? - simplywall.st

Is Nuvation Bio (NYSE:NUVB) Using Debt In A Risky Way? simplywall.st

44.6 Month Survival Milestone: Nuvation Bio's IBTROZI Demonstrates Breakthrough Results in Lung Cancer Studies - Stock Titan

44.6 Month Survival Milestone: Nuvation Bio's IBTROZI Demonstrates Breakthrough Results in Lung Cancer Studies Stock Titan

Nuvation Bio to Present New Nonclinical Data for Taletrectinib at the American Association for Cancer Research Annual Meeting 2025 - Business Wire

Nuvation Bio to Present New Nonclinical Data for Taletrectinib at the American Association for Cancer Research Annual Meeting 2025 Business Wire

Nuvation Bio Shines with New Price Target and Bullish Signals - timothysykes.com

Nuvation Bio Shines with New Price Target and Bullish Signals timothysykes.com

Nuvation Bio: A Real Shot To Move The Needle In Lung Cancer Subtypes (NYSE:NUVB) - Seeking Alpha

Nuvation Bio: A Real Shot To Move The Needle In Lung Cancer Subtypes (NYSE:NUVB) Seeking Alpha

Honeywell Collaborates With Nuvation Energy To Add Flexible Battery Management System To Honeywell Ionic - Honeywell

Honeywell Collaborates With Nuvation Energy To Add Flexible Battery Management System To Honeywell Ionic Honeywell

Nuvation Bio Stock Shows Potential with Strategic Developments - timothysykes.com

Nuvation Bio Stock Shows Potential with Strategic Developments timothysykes.com

Nuvation Bio Receives Approval from China’s National Medical Products Administration for Taletrectinib for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer - Business Wire

Nuvation Bio Receives Approval from China’s National Medical Products Administration for Taletrectinib for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer Business Wire

Nuvation halts BET inhibitor program after considering phase 1 solid tumor data - Fierce Biotech

Nuvation halts BET inhibitor program after considering phase 1 solid tumor data Fierce Biotech

Nuvation Bio Stock: Time to Buy or Sell? - timothysykes.com

Nuvation Bio Stock: Time to Buy or Sell? timothysykes.com

Nuvation Bio jumps after insiders purchase shares worth over $1.1M - Seeking Alpha

Nuvation Bio jumps after insiders purchase shares worth over $1.1M Seeking Alpha

Nuvation Bio - Pending Approval Shot In ROSL+ NSCLS Looks A Major Upside Catalyst (NUVB) - Seeking Alpha

Nuvation Bio - Pending Approval Shot In ROSL+ NSCLS Looks A Major Upside Catalyst (NUVB) Seeking Alpha

Nuvation Bio to buy AnHeart - The Pharma Letter

Nuvation Bio to buy AnHeart The Pharma Letter

Beaten-Down Biotech Stocks Nuvation and Ardelyx See Big Insider Buys - Barron's

Beaten-Down Biotech Stocks Nuvation and Ardelyx See Big Insider Buys Barron's

Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors - Investing News Network

Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors Investing News Network

Nuvation Bio stock in focus as FDA clears Ibtrozi (NUVB:NYSE) - Seeking Alpha

Nuvation Bio stock in focus as FDA clears Ibtrozi (NUVB:NYSE) Seeking Alpha

Nuvation to cut workforce by 35% as it scraps lead drug program - BioPharma Dive

Nuvation to cut workforce by 35% as it scraps lead drug program BioPharma Dive

Nuvation Bio and Panacea Announce Business Combination Agreement, Creating a Publicly Listed Leader in Oncology Drug Development - PR Newswire

Nuvation Bio and Panacea Announce Business Combination Agreement, Creating a Publicly Listed Leader in Oncology Drug Development PR Newswire

NUVB Stock Price and Chart — NYSE:NUVB - TradingView

NUVB Stock Price and Chart — NYSE:NUVB TradingView

Nuvation Engineering Launches Nuvation Energy - Renew Economy

Nuvation Engineering Launches Nuvation Energy Renew Economy

Top Nuvation Engineering Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant